ChromaCode to Launch HDPCR™ Multiplexing Technology and Host Corporate Workshop at AMP 2018
October 23, 2018BioWorld MedTech: “Chromacode looks to battle tickborne pathogens with new assay”
December 11, 2018CARLSBAD, Calif., Nov. 19, 2018 /PRNewswire/– ChromaCode, Inc., a company redefining molecular testing through data science, today announced that President and Chief Executive Officer, Gregory Gosch, will present in the 30th Annual Piper Jaffray Healthcare Conference, which takes place November 27-29 in New York, NY
ChromaCode’s presentation details include:
Event: 30th Annual Piper Jaffray Healthcare Conference
Date: Wednesday, November 28, 2018
Time: 11:50 a.m. – 12:10 p.m. EST
Location: Harlem Track – Kennedy 2 Ballroom, Lotte New York Palace
An audio webcast of the Company’s presentation can be requested here.
About ChromaCode
ChromaCode’s HDPCR™ multiplexing technology is the unique coupling of widely-used, low-cost chemistries with proprietary software using data science algorithms. We use this technology to empower the enormous, global installed base of real-time and digital PCR instrumentation to perform higher multiplexing at a very low cost. Using HDPCR™, ChromaCode is seeking to broaden global access to advanced diagnostics, reduce healthcare costs, and rapidly address unmet healthcare testing needs.
|
IR Contact: |
PR Contact: |
|
Lee Roth |
Kirsten Thomas |
|
The Ruth Group |
The Ruth Group |
|
646-536-7012 |
508-280-6592 |